| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |